Research has found that depression not only affects emotions and cognition but may also hinder the growth of new neurons in the brain. A study analyzing human hippocampal tissue has shown that individuals with depression had higher numbers of cells resembling neural stem cells but fewer cells at the intermediate stage of becoming mature neurons. This pattern suggests that the process of neurogenesis may be interrupted in those with depression.
Read More
The hippocampus, crucial for memory and emotional processing, is one of the brain regions capable of producing new neurons throughout adulthood. A team funded by the NIH analyzed approximately half a million cells from the hippocampi of 30 deceased donors—19 without depression and 11 with depression. Importantly, none of the donors with depression had taken antidepressants in the three months prior to their death, minimizing the influence of recent medication on the observed cellular differences.
Although the presence of more neural stem cells might seem encouraging, the study revealed a concerning drop in the number of intermediate cells. This suggests that while the brain has a supply of precursor cells, it struggles to advance them to the next stages of development, creating what researchers identified as a potential bottleneck in neurogenesis.
These findings could help clarify the memory issues often associated with depression, such as difficulties in concentration and negative bias in thinking. The hippocampus's role in memory organization makes it a critical area of interest for understanding the impact of depression on cognitive functions. However, the context of depression is complex, influenced by various biological factors including stress hormones, inflammation, genetics, and life experiences.
Postmortem studies, while insightful, provide only a snapshot of cellular changes at the end of life. They do not clarify the onset or causation of these changes relative to depression. The sample size, particularly among donors with depression, was modest, necessitating further research to validate these findings and explore whether treatments could restore normal neurogenesis.
This study highlights a potential therapeutic target rather than an immediate solution for patients. It emphasizes the adult brain's capacity for change and reinforces the understanding that depression is linked to measurable alterations in brain function and cellular biology. The next step for researchers is to determine whether the observed disruptions in neurogenesis can be reversed and if such changes can lead to improvements in depressive symptoms.